Assessing Cognitive Concerns in Parkinson's Disease

This chapter focuses on evaluating cognitive issues in Parkinson's disease, highlighting the need to distinguish between typical symptoms and other causes. It discusses the role of neuropsychological testing and recent advancements in diagnostics, including FDA-approved Alzheimer's biomarkers, in improving patient assessments and treatment plans.